Novozymes

Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology

Retrieved on: 
Thursday, February 15, 2024

“Meatable is at an exciting juncture in our growth trajectory as we prepare to launch our consumer products in Singapore and host our first tasting in the EU.

Key Points: 
  • “Meatable is at an exciting juncture in our growth trajectory as we prepare to launch our consumer products in Singapore and host our first tasting in the EU.
  • On the Meatable Board, Mr. Abony will support the company’s management team by advising on commercial development initiatives in the U.S. as well as future transactions.
  • “Compared to others in its category, Meatable is highly differentiated through its industry-first technology and phased approach.
  • “Meatable is working at the forefront of food technology and is a clear-cut leader in the cultivated meat space,” said Ms. Malarkey.

Legacy Novozymes delivers solid last full-year results

Retrieved on: 
Thursday, February 1, 2024

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023.

Key Points: 
  • Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023.
  • This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
  • In the 2023 financial year, legacy Novozymes delivers 5% organic sales growth – 6% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 25.4%, and ROIC including goodwill before special items* of 16.5%.
  • “Legacy Novozymes has leveraged its strengths of a well-diversified portfolio, unique production capabilities, and broad market presence to deliver strong growth in a volatile market.

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Retrieved on: 
Monday, January 29, 2024

Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.

Key Points: 
  • Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.
  • Ester Baiget, President and CEO of Novonesis, says:
    We have successfully combined Novozymes and Chr.
  • Hansen and today we come together as one leading global biosolutions partner.
  • Hansen will create a leading global biosolutions partner with a broad biological toolbox and a diversified portfolio in attractive markets.

Marine Enzymes Market to increase by USD 54.62 million from 2023 to 2028, Advanced Enzyme Technologies Ltd., Air Liquide SA, Antozyme Biotech Pvt. Ltd., and more among key companies- Technavio

Retrieved on: 
Thursday, December 14, 2023

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The marine enzymes market is expected to grow by USD 54.62 million from 2023 to 2028.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The marine enzymes market is expected to grow by USD 54.62 million from 2023 to 2028.
  • Growing demand for food enzymes is notably driving the marine enzymes market.
  • However, factors such as the complex production process of marine enzymes may impede market growth.
  • We provide a detailed analysis of 20 companies operating in the marine enzymes market including Advanced Enzyme Technologies Ltd., Air Liquide SA, Antozyme Biotech Pvt.

Microbial Agricultural Inoculants Market to increase by USD 243.73 million between 2023 to 2028, AquaBella Organic Solutions LLC, BASF SE, Bayer AG and more among key companies - Technavio

Retrieved on: 
Friday, December 8, 2023

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- The microbial agricultural inoculants market size is expected to grow by USD 243.73 million from 2023 to 2028.

Key Points: 
  • NEW YORK, Dec. 8, 2023 /PRNewswire/ -- The microbial agricultural inoculants market size is expected to grow by USD 243.73 million from 2023 to 2028.
  • Rising concerns over the use of chemical fertilizers and pesticides in agriculture are notably driving the microbial agricultural inoculants market.
  • However, factors such as a lack of awareness of microbial agricultural inoculants among farmers may impede market growth.
  • Microbial Agricultural Inoculants Market 2024-2028: Company Analysis
    BASF SE - The company offers microbial agricultural inoculants such as Poncho Votivo bio seeds made up of Bacillus microbial and Votivo prime made up of Bacillus firmus microbial, under its brand called BioSolutions.

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment

Retrieved on: 
Thursday, November 9, 2023

Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an enzymatic solution designed to transform the feedstock pre-treatment process.

Key Points: 
  • Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an enzymatic solution designed to transform the feedstock pre-treatment process.
  • As the world seeks sustainable alternatives to traditional fuels, renewable diesel and SAF production have taken center stage.
  • By 2030, vegetable oils are projected to account for over 40% of global feedstock used in renewable diesel and SAF production.
  • For more information about Quara LowP and Novozymes' biosolutions for renewable diesel feedstocks, please visit https://www.novozymes.com/en/solutions/renewable-diesel .

Michael Burns Joins Invizyne as Executive Vice President of Energy Transition

Retrieved on: 
Wednesday, November 8, 2023

Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC , (NASDAQ:MDBH) ("MDB") ­– today announced the appointment of Michael Burns to its senior leadership team as Executive Vice President, Energy Transition.

Key Points: 
  • Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC , (NASDAQ:MDBH) ("MDB") ­– today announced the appointment of Michael Burns to its senior leadership team as Executive Vice President, Energy Transition.
  • "Michael Burns brings two decades worth of business strategy and development, global licensing, project development, and project finance expertise in the sustainable energy and synthetic biology industries to Invizyne.
  • We are honored to have an executive with his gravitas and experience join the team to head up our new Energy Transition business unit,” said Mo Hayat, CEO of Invizyne.
  • He also served in strategy and development roles at Verenium Corporation, a specialized enzyme biotechnology company that was acquired by BASF.

Not Just Yogurt Anymore

Retrieved on: 
Thursday, October 26, 2023

FRANKLINTON, N.C., Oct. 26, 2023 /PRNewswire/ -- Novozymes is excited to launch ProSilience™ HU58, a probiotic with superior stability and low cost-in-use that may help change the way America eats breakfast (and snacks and other meals).

Key Points: 
  • The probiotic can withstand harsh processing conditions, allowing it to become an ingredient in entirely new food categories – for example, breakfast cereal or coffee.
  • "ProSilience™ HU58 provides the clinically supported digestive and immune benefits that consumers demand," says Stephen Quinn, Novozymes Industry Manager, Functional Foods.
  • The new product is a part of Novozymes' commitment to driving innovation in biosolutions and promoting healthy, sustainable food choices.
  • Easy handling: ProSilience™ HU58 is easy to formulate, easy to incorporate into existing production lines, and supported by Novozymes Technical Service.

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations

Retrieved on: 
Thursday, October 26, 2023

“The results we are presenting today are another proof-point to the strength of our well-diversified portfolio and broad market exposure.

Key Points: 
  • “The results we are presenting today are another proof-point to the strength of our well-diversified portfolio and broad market exposure.
  • Sales growth in the nine months of 2023 was within expectations, benefitting from a well-diversified portfolio and broad market exposure.
  • In Food, Beverages & Human Health, sales growth improved in Q3 as expected, with destocking gradually levelling off as well as improvements in Human Health.
  • Bioenergy was the main driver of growth in developed markets, while Agriculture, Animal Health & Nutrition delivered solid growth.

Comprehensive Report on Next-Generation Biofuels Market Explores Sustainable Solutions and Regulatory Initiatives Shaping the Future

Retrieved on: 
Thursday, October 12, 2023

The global Next-Generation Biofuels market is set for substantial growth, with a projected value surpassing USD 9.8 billion in 2023.

Key Points: 
  • The global Next-Generation Biofuels market is set for substantial growth, with a projected value surpassing USD 9.8 billion in 2023.
  • As the world faces rising energy demand and the need for energy security, the Next-Generation Biofuels market offers a sustainable solution.
  • The Next-Generation Biofuels Market Report addresses several critical questions:
    How is the Next-Generation Biofuels market evolving?
  • The report profiles key players in the Next-Generation Biofuels market, offering insights into their operations, growth prospects, and market presence.